Page last updated: 2024-10-26

disopyramide and Interstitial Nephritis

disopyramide has been researched along with Interstitial Nephritis in 1 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Research Excerpts

ExcerptRelevanceReference
"The pharmacokinetics of disopyramide was studied in 15 patients with renal dysfunction (4 with pyelonephritis, 7 with glomerular nephritis and 4 with interstitial nephritis)."3.67Does alpha 1-acid glycoprotein reduce the unbound metabolic clearance of disopyramide in patients with renal impairment? ( Braun, J; Gluth, WP; Oie, S; Sörgel, F, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braun, J1
Sörgel, F1
Gluth, WP1
Oie, S1

Other Studies

1 other study available for disopyramide and Interstitial Nephritis

ArticleYear
Does alpha 1-acid glycoprotein reduce the unbound metabolic clearance of disopyramide in patients with renal impairment?
    European journal of clinical pharmacology, 1988, Volume: 35, Issue:3

    Topics: Adult; Aged; Creatinine; Disopyramide; Female; Glomerulonephritis; Humans; Male; Metabolic Clearance

1988